| Date | Time | Source | Headline | Symbol | Company |
| 06/13/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs | NYSE:QGEN | Qiagen NV |
| 06/12/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth | NYSE:QGEN | Qiagen NV |
| 06/11/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance | NYSE:QGEN | Qiagen NV |
| 06/06/2024 | 4:50PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:QGEN | Qiagen NV |
| 06/06/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period | NYSE:QGEN | Qiagen NV |
| 06/05/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe | NYSE:QGEN | Qiagen NV |
| 06/03/2024 | 2:00AM | GlobeNewswire Inc. | QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care | NYSE:QGEN | Qiagen NV |
| 05/31/2024 | 4:42PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:QGEN | Qiagen NV |
| 05/30/2024 | 5:55PM | GlobeNewswire Inc. | QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications | NYSE:QGEN | Qiagen NV |
| 05/30/2024 | 4:45PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:QGEN | Qiagen NV |
| 05/30/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications | NYSE:QGEN | Qiagen NV |
| 05/29/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine | NYSE:QGEN | Qiagen NV |
| 05/14/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support | NYSE:QGEN | Qiagen NV |
| 05/13/2024 | 2:00AM | GlobeNewswire Inc. | QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results | NYSE:QGEN | Qiagen NV |
| 05/07/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics | NYSE:QGEN | Qiagen NV |
| 05/02/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications | NYSE:QGEN | Qiagen NV |
| 04/29/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance | NYSE:QGEN | Qiagen NV |
| 04/24/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance | NYSE:QGEN | Qiagen NV |
| 04/09/2024 | 9:48AM | GlobeNewswire Inc. | QIAGEN N.V. to release results for Q1 2024 and hold webcast | NYSE:QGEN | Qiagen NV |
| 04/03/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 | NYSE:QGEN | Qiagen NV |
| 03/25/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system | NYSE:QGEN | Qiagen NV |
| 03/18/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements | NYSE:QGEN | Qiagen NV |
| 03/11/2024 | 5:59AM | GlobeNewswire Inc. | QIAGEN announces Form 20-F annual report filing for 2023 results | NYSE:QGEN | Qiagen NV |
| 02/27/2024 | 5:44PM | GlobeNewswire Inc. | QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery | NYSE:QGEN | Qiagen NV |
| 02/27/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification | NYSE:QGEN | Qiagen NV |
| 02/15/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification | NYSE:QGEN | Qiagen NV |
| 02/08/2024 | 9:47AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:QGEN | Qiagen NV |
| 02/06/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability | NYSE:QGEN | Qiagen NV |
| 01/25/2024 | 10:00AM | GlobeNewswire Inc. | QIAGEN announces partnership with Penn State University to advance microbiome sciences | NYSE:QGEN | Qiagen NV |
| 01/23/2024 | 4:13PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:QGEN | Qiagen NV |